ÂÜÀòÂÒÂ×

Anmol Grover, Ph.D., is an experienced leader in strategy and portfolio management with significant expertise in the life sciences sector. Currently serving as Director of Strategy and Portfolio Management at both Amgen and Horizon, Anmol has previously held key positions, including Associate Principal at Halloran Consulting Group, Inc. and Life Sciences Consultant at Putnam Associates. Expertise encompasses clinical development planning, product opportunity assessment, competitive landscape analysis, and pricing strategies for various diseases, including oncology and neurodegenerative disorders. Anmol's academic foundation is a Ph.D. in Biochemistry, Biophysics, and Molecular Biology from Carnegie Mellon University, complemented by earlier roles in virology and vaccine research.